Governor Tarcísio de Freitas (Republicans) sanctioned this Tuesday afternoon (31) the law that provides for the distribution of products based on cannabidiol (CBD), a substance derived from cannabis, in the SUS (Unified Health System) in São Paulo.
The law was approved at Alesp (São Paulo Legislative Assembly) in December 2022, after three years of processing the project. After approval, a petition with 40,000 signatures and a letter from the OAB-SP in defense of the proposal pushed for the sanction.
“Sao Paulo will be at the forefront in supplying drugs based on ÇAnnabis by the SUS for various pathologies. Many families will benefit”, celebrated França, through social networks. The deputy also said that the law is a victory, especially for people diagnosed with autism and rare syndromes, in addition to epileptics and elderly people with Parkinson’s.
When the project (PL 1,180/2019) was approved at Alesp, state deputy Caio França (PSB), one of the authors of the proposal, highlighted the need to eliminate judicial demands on access to medical marijuana. And he recalled that, despite the possibility of importation, access to cannabidiol extracts and oils remains restricted to the vast majority of the population, as it comes up against high costs and bureaucracy.
The number of lawsuits that seek to oblige the state of São Paulo to supply Cannabis-derived products has grown almost 18 times (about 1,750%) in four years, from 8 in 2015 to 148 in the first half of 2019.
Thus, the objective of the new law is to democratize access, especially for the most needy families, without the need to go to court to guarantee the right to health.
The law is the responsibility of the State Department of Health, which will define the competencies at each level of action through the creation of a working commission to implement the guidelines, with the participation of technicians and representatives of non-profit support and research associations. and organizations representing patients.
I have over 8 years of experience in the news industry. I have worked for various news websites and have also written for a few news agencies. I mostly cover healthcare news, but I am also interested in other topics such as politics, business, and entertainment. In my free time, I enjoy writing fiction and spending time with my family and friends.
